HLscience Co. Ltd (239610) - Total Liabilities
Based on the latest financial reports, HLscience Co. Ltd (239610) has total liabilities worth ₩2.15 Billion KRW (≈ $1.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is HLscience Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
HLscience Co. Ltd - Total Liabilities Trend (2014–2024)
This chart illustrates how HLscience Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 239610 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
HLscience Co. Ltd Competitors by Total Liabilities
The table below lists competitors of HLscience Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Helport AI Limited Ordinary Shares
NASDAQ:HPAI
|
USA | $19.72 Million |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩9.72 Billion |
|
DATRIX S.P.A.
F:BW6
|
Germany | €19.35 Million |
|
Sun Summit Minerals Corp
V:SMN
|
Canada | CA$3.15 Million |
|
GUH Holdings Bhd
KLSE:3247
|
Malaysia | RM220.56 Million |
|
CT AUTOMOTIVE GROUP -005
F:X7X
|
Germany | €54.88 Million |
|
Telefast Indonesia
JK:TFAS
|
Indonesia | Rp42.65 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down HLscience Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HLscience Co. Ltd (239610) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 22.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.02 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HLscience Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HLscience Co. Ltd (2014–2024)
The table below shows the annual total liabilities of HLscience Co. Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩3.23 Billion ≈ $2.19 Million |
-4.20% |
| 2023-12-31 | ₩3.38 Billion ≈ $2.29 Million |
-26.66% |
| 2022-12-31 | ₩4.60 Billion ≈ $3.12 Million |
-56.61% |
| 2021-12-31 | ₩10.61 Billion ≈ $7.19 Million |
-5.46% |
| 2020-12-31 | ₩11.22 Billion ≈ $7.60 Million |
-15.08% |
| 2019-12-31 | ₩13.21 Billion ≈ $8.95 Million |
+56.85% |
| 2018-12-31 | ₩8.42 Billion ≈ $5.71 Million |
+83.06% |
| 2017-12-31 | ₩4.60 Billion ≈ $3.12 Million |
+4.71% |
| 2016-12-31 | ₩4.39 Billion ≈ $2.98 Million |
+53.45% |
| 2015-12-31 | ₩2.86 Billion ≈ $1.94 Million |
-21.11% |
| 2014-12-31 | ₩3.63 Billion ≈ $2.46 Million |
-- |
About HLscience Co. Ltd
HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more